神经生物学分子角度研究的现状和展望

神经生物学分子角度研究的现状和展望邹冈（中国科学院上海药物研究所２０００３１）人脑是神经系统最高的组织形式,是最复杂的器官,是思维的物质基础。神经科学被称为科学的最前沿领域或最大的挑战,因此受到极大的重视并取得了重大进展。在这全面进展中,人们不难发现...     

哺乳动物脑下垂体前叶的直接神经调节

内分泌系统的活动受神经系的调节。脑下垂体前叶,作为内分泌系的核心器官,其神经调节历来是神经内分泌学的一个中心课题。早期对于垂体前叶的神经支配有过大量的研究,从无神经支配、仅有少量神经纤维到有较丰富神经,众说不一。多数认为这些神经纤维属血管运动性,主要来自交感神经系。也有从下丘脑发出大量神经纤维到垂体前叶的报告。Ha-     

垂体前叶滤泡星状细胞来源的免疫组织化学研究

应用纤维连接素(Fn)、S—100蛋白、胶质纤维酸性蛋白(GFAP)、细胞角蛋白(CK)和神经特异性烯醇蛋白(NSE)5种抗体对63例正常人垂体前叶内滤泡星状细胞(FSC)进行了免疫细胞化学研究。结果表明:人FSC内26.9％S_(100)阳性,9.3％GFAP阳性,63.8％两者都为阳性。CK、NSE和Fn均为阳性。从而提示了FSC来自神经外胚层的原始细胞而非Rathke's囊上皮的残留。     

眼镜蛇神经毒的免疫化学研究（摘要）

台湾产的眼镜蛇(Naja naja)的蛇毒经分离所得结晶体,属强碱性的突触后神经毒素,分子量为7000,是双硫键结合的多肽物,(如图1)     

炎症和氧化应激对内皮祖细胞动员及其功能的影响

内皮祖细胞对于维持血管内皮完整性和血管稳态具有重要作用.增强EPC的数量和功能可使心血管疾病患者获益.炎症、氧化应激对内皮祖细胞动员及其功能发挥具有重要影响,本文着重综述炎症和氧化应激对内皮祖细胞动员的调控,并探讨增进内皮祖细胞数量和功能的相关治疗策略.     

STAT3小分子抑制剂FLLL31对卵白蛋白致敏小鼠气道炎症治疗活性的初步研究

目的:研究新结构化合物FLLL31抑制卵白蛋白(OVA)致敏引发的小鼠气道炎症的活性,探讨FLLL31治疗哮喘的初步疗效。方法:雄性BALB/c小鼠(18~20 g)随机分为4组,每组10只,包括正常对照组(Control组)、模型对照组(OVA组)、地塞米松组(1 mg/kg,腹腔注射)和FLLL31组(15 mg/kg,口服灌胃)。各组小鼠分别于第0 d和第14 d致敏,每只鼠腹腔注射20μg OVA和2.25 mg Al(OH)3凝胶,FLLL31自致敏第24 d开始给药,给药周期为7 d;于第28、29、30 d以气管滴入OVA进行攻击,攻击前1 h给予受试化合物FLLL31及阳性药地塞米松。结果:小鼠肺灌流液炎症细胞分类计数、肺组织病理分析等实验结果证明,FLLL31以15 mg/kg连续给药7 d后,与模型组相比,抑制了小鼠肺部气道中炎症细胞的浸润,明显改善OVA致敏引发的小鼠气道炎症症状;ELISA结果证明FLLL31降低小鼠肺灌流液中炎症因子白细胞介素6的含量;免疫组化结果显示FLLL31降低OVA致敏小鼠肺部白细胞介素6受体浓度,减少中性粒细胞标志物淋巴细胞抗原6G(Ly6G)的表达(P0.05)。结论:特异抑制STAT3的新结构化合物FLLL31在体内对OVA致敏小鼠模型气道炎症有较好的改善和免疫调节活性。     

TOLL样受体在睾丸炎症反应与精子发生中的功能

睾丸局部炎症反应以及系统性炎症疾病均可以损伤雄性生殖能力,近年来对于TOLL样受体(Toll-like recep-tor,TLR)调节睾丸功能的研究有了较大进展,为认识炎症反应与雄性生殖障碍之间的关系提供了新的线索。TLR介导的炎症信号通路在睾丸内除了抵御病原体外,还可以调节多种睾丸细胞的功能,从而影响精子发生。炎症对精子发生的影响主要由于循环系统和睾丸中炎症因子增多,它们可以破坏生精细胞的正常发育,损害睾丸体细胞对精子发生的正常调节。相关机理的深入研究可能为雄性不育的预防与治疗提供新的思路,本文将综述TLR介导的系统性炎症疾病及睾丸局部炎症反应干扰雄性生育的研究进展。     

Critical Role of Cys168 in Noggin Protein＇s Biological Function

Previous studies have indicated that noggin exerts its neural inducing effect by binding and antagonizing bone morphogenetic protein 4 (BMP4). In order to further clarify the relationship between the structure and the function of noggin, and elucidate the possible mechanism responsible for noggin-BMP4 interaction, we generated three noggin mutants, C168S, C174S and C197S, by using a site-directed mutagenesis method. Ectopic expression of wild-type (WT) noggin, C174S or C197S, in Xenopus animal caps (ACs) by mRNA injection converted the explants (prospective ectoderm) into neural tissue, as indicated by the neural-like morphology and expression of the neural cell adhesion molecule (NCAM) in the ACs. In contrast, ACs expressing C168S suffered an epidermal fate similar to the control caps. Similarly, among the three mutants, only C168S lost the dorsalizing function. These studies highlight the critical role played by Cys168 in noggin‘s biological activities. It probably participates in the formation of an intermolecular disulfide bridge.     

Getting the right stuff： controlling neural stem cell state and fate in vivo and in vitro with biomaterials

Stem cell therapy holds great promises in medical treatment by, e.g., replacing lost cells, re-constitute healthy cell populations and also in the use of stem cells as vehicles for factor and gene delivery. Embryonic stem cells have rightfully attracted a large interest due to their proven capacity of differentiating into any cell type in the embryo in vivo. Tissue-specific stem ceils are however already in use in medical practice, and recently the first systematic medical trials involving human neural stem cell （NSC） therapy have been launched. There are yet many obstacles to overcome and procedures to improve. To ensure progress in the medical use of stem cells increased basic knowledge of the molecular mechanisms that govern stem cell characteristics is necessary. Here we provide a review of the literature on NSCs in various aspects of cell therapy, with the main focus on the potential of using biomaterials to control NSC characteristics, differentiation, and delivery. We summarize results from studies on the characteristics of endogenous and transplanted NSCs in rodent models of neurological and cancer diseases, and highlight recent advancements in polymer compatibility and applicability in regulating NSC state and fate. We suggest that the development of specially designed polymers, such as hydrogels, is a crucial issue to improve the outcome of stem cell therapy in the central nervous system.     

中国脊髓灰质炎Ⅱ型疫苗相关分离株病毒性状的观察

对１９９４年中国分离的１３株脊髓灰质炎Ⅱ型疫苗相关株进行了ＰＣＲ－ＲＦＬＰ分析,发现７株为重组病毒,毒力较疫苗株有回复,在Ⅱ型脊髓灰质炎病毒基因序列上,对于神经毒力有重要影响的第４８１位核苷酸发生突变,另一个被视为重要位点的２９０８位核苷酸无一发生变化,反而在２９０９位核苷发生了高频率的点突变,意味着２９０９位点在中国Ⅱ型疫苗相关株的自然变异中可能起着重要作用。